Explore some of the top defensive stocks to buy and hold ahead of Donald Trump's Liberation Day tariffs next week ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others ...

With reference to AbbVie's (NYSE:ABBV) and Gubra A/S' (CPSE:GUBRA) joint announcement of March 3, 2025 regarding a license agreement to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Discover whether AbbVie or Sanofi holds the edge in the global immunology market and find out which stock shows more ...

AbbVie (ABBV) rebounds after losses, gaining ~% as analysts stay bullish. Discover why its obesity drug deal boosts long-term ...

Even before she took office, Protect our Future PAC and WEB3 Forward, two PACs funded by crypto moguls such as Bankman-Fried, ...

Under the new collaboration, OpenFold will produce a fine-tuned version of its model that’s trained on AbbVie and Johnson & ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery PlatformALISO VIEJO, Calif., March ...

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) Q4 2024 Earnings Call Transcript March 26, 2025 CollPlant Biotechnologies Ltd.

In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...